Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "MOMENTUM"

370 News Found

NFHS-5 shows momentum towards achieving SDG
News | November 25, 2021

NFHS-5 shows momentum towards achieving SDG

The main objective of successive rounds of the NFHS is to provide reliable and comparable data relating to health and family welfare and other emerging issues


USAID announces Momentum country programme
Public Health | November 15, 2021

USAID announces Momentum country programme

The initiative will engage adolescents and youth of India in decisions about their reproductive health


Lonza reports strong momentum in H1 2021
News | July 24, 2021

Lonza reports strong momentum in H1 2021

The company confirms an upward revision to its 2021 Outlook, reflecting the expectation to achieve mid-teens CER sales growth


Artemis Medicare Q4 FY26 revenue rises 16.4% to Rs. 27,923 lakh, net profit jumps 32.1%
Hospitals | May 09, 2026

Artemis Medicare Q4 FY26 revenue rises 16.4% to Rs. 27,923 lakh, net profit jumps 32.1%

The hospital chain reported strong growth driven by its Gurugram facility, international patient inflow, and operational efficiencies


Lonza surges on biologics boom
News | May 09, 2026

Lonza surges on biologics boom

Expands manufacturing push & locks in major growth deals


Lupin Q4 FY26 PBT jumps 115% to Rs 19,280 million
News | May 08, 2026

Lupin Q4 FY26 PBT jumps 115% to Rs 19,280 million

U.S. business drives strong growth as Lupin reports 57% rise in Q4 U.S. sales and 43% increase in gross profit


Dabur profit jumps 16% as FMCG growth gains pace
News | May 08, 2026

Dabur profit jumps 16% as FMCG growth gains pace

Hair care & quick commerce shine


Vijaya Diagnostic Q4FY26 revenue jumps 27%, EBITDA margin expands to 43.5%
Healthcare | May 08, 2026

Vijaya Diagnostic Q4FY26 revenue jumps 27%, EBITDA margin expands to 43.5%

With robust FY26 growth, plans AI-led diagnostics and genomic testing expansion


Bayer strikes $2.45 billion deal for breakthrough blindness drug developer Perfuse Therapeutics
News | May 07, 2026

Bayer strikes $2.45 billion deal for breakthrough blindness drug developer Perfuse Therapeutics

The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy


Practo’s AI-led healthcare marketplace crosses $100 million GMV amid global expansion
Digitisation | May 07, 2026

Practo’s AI-led healthcare marketplace crosses $100 million GMV amid global expansion

Company handles 20,000+ AI-driven calls and chats daily as it scales agentic AI systems across healthcare workflows